14.02.2018 • Product

Johnson Matthey Offers Novel Gusev Catalyst

UK specialty chemical and technology group Johnson Matthey announced the successful scale-up and commercial availability of a novel Gusev catalyst for ester hydrogenation. Using licensed technology developed by GreenCentre Canada, the catalyst combines high activity with high chemoselectivity that could revolutionize industrial applications of ester hydrogenation.

The technology, which was originally conceived and developed in the laboratories of professor Dmitri Gusev of Wilfrid Laurier University, was exclusively licensed from GreenCentre Canada, a provider of intellectual property services, to Johnson Matthey in 2016. Following this agreement, Johnson Matthey has scaled the manufacturing process of the Gusev catalyst, known as Ru-SNS, that shows exceptional activity for the important chemical transformation known as ester hydrogenation.

Ester hydrogenation is an essential transformation in the chemical industry used to form primary alcohols. It is widely used in the manufacture of a variety of commercial products including pharmaceuticals, detergents, cosmetics, flavours and fragrances.

Compared with existing industrial processes, the Gusev catalyst offers exceptional reactivity and improved selectivity, as well as possessing a higher tolerance of challenging functional groups. Reactions using this catalyst are also safer, owing to the milder operating conditions, and produce less environmental waste. The advantages offered by this catalytic process have the potential to greatly improve the economic and environmental performance of many large-scale commercial chemical processes.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.